-transparent.png){kind=logo}
A series of rabbit experiments has been carried out to investigate the potential antigenicity of the heat-treated foetal calf serum which is commonly used to enhance viability of preserved aortic homograft valves. In all presensitised animals, the calf serum content of the nutrient medium which infiltrated the aortic wall during preservation provoked a heavy second-set reaction. It is concluded that heat-treated foetal calf serum is a potent heterologous antigen and should not be used for preserving human tissue selected for transplantation.
Related Publications
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
June 1975,
Thorax,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
November 2001,
The Journal of heart valve disease,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
March 1964,
Oral surgery, oral medicine, and oral pathology,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
November 1958,
Nature,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
May 1969,
Circulation,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
November 1970,
Lancet (London, England),
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
March 1974,
The British journal of surgery,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
May 1986,
The American journal of otology,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
October 1959,
The Medical journal of Australia,
E Bodnar, and
E G Olsen, and
R Florio, and
D Guerreiro, and
D N Ross
October 1971,
Thoraxchirurgie, vaskulare Chirurgie,
